HederaDX

Transforming Oncology

Switzerland
Seed in 2022

Hedera Dx liquid biopsy solution radically streamlines tumor profiling and cancer treatment monitoring for all patients, enabling every hospital laboratory to run CE-IVDR compliant and clinically actionable liquid biopsies in-house.

The Founder

The story

Inventure team